Evolent Health, Inc.
NYSE:EVH
24.96 (USD) • At close October 17, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -113.04 | -19.164 | -37.601 | -334.246 | -305.58 | -54.191 | -69.767 | -226.778 | 319.814 | -25.246 | 20.023 | -19.263 |
| Afschrijvingen & Amortisatie
| 123.415 | 67.195 | 60.037 | 61.475 | 60.913 | 44.515 | 32.368 | 17.224 | 7.166 | 0 | 1.208 | 0.114 |
| Uitgestelde Inkomstenbelasting
| -31.272 | 0.342 | -0.526 | -1.132 | -23.124 | 0.044 | -7.271 | -10.755 | 23.46 | 0 | 4.241 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 40.501 | 33.981 | 16.711 | 14.606 | 15.618 | 17.609 | 20.437 | 22.501 | 14.73 | 0 | 0.091 | 0.087 |
| Verandering in Werkkapitaal
| 21.892 | -104.441 | -13.645 | -55.319 | 0.331 | -34.866 | -7.284 | -4.429 | 2.158 | -49.896 | 6.227 | -1.792 |
| Vorderingen
| -164.694 | -102.98 | -5.779 | -47.017 | 6.326 | -24.503 | -11.258 | -11.044 | 11.756 | 0 | -8.67 | -1.792 |
| Voorraden
| -10.746 | 0 | -14.116 | 47.017 | -19.503 | 0.644 | -1.834 | 5.108 | -5.766 | 0 | 2.919 | 0 |
| Crediteuren
| -6.723 | 13.165 | 7.25 | 3.547 | -5.48 | 7.598 | 5.563 | -6.371 | 2.764 | 0 | -0.843 | 0 |
| Overig Werkkapitaal
| 204.055 | -14.626 | -1 | -58.866 | 18.988 | -18.605 | 0.245 | 7.878 | -6.596 | -49.896 | 12.821 | 0 |
| Overige Niet-Contante Posten
| 101.086 | 10.534 | 13.771 | 298.391 | 209.197 | 6.238 | 3.559 | 166.727 | -387.157 | 75.142 | -45.419 | 6.382 |
| Kasstroom uit Operationele Activiteiten
| 142.582 | -11.553 | 38.747 | -16.225 | -42.645 | -20.651 | -27.958 | -35.51 | -19.829 | -75.094 | -13.629 | -12.767 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -28.745 | -38.361 | -24.983 | -29.473 | -35.534 | -39.55 | -27.848 | -15.526 | -6.515 | -11.034 | -10.438 | -2.329 |
| Netto Overnames
| 0.87 | 5.552 | -34.794 | -0.3 | -96.055 | -139.601 | -4.822 | -85.56 | 13.065 | 0 | -15.521 | 0 |
| Aankoop van Beleggingen
| -0.87 | -5.552 | -2.995 | -11.17 | -11.125 | -10.01 | -3.805 | -9.09 | -54.234 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0.87 | 5.552 | 0.5 | 143.441 | 2.575 | 0.349 | 44.21 | 9.379 | 4 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -387.669 | -226.306 | 46.486 | 158.574 | -41.495 | 28.437 | -20 | -6.09 | -50.234 | 7.458 | 0.05 | -1.45 |
| Kasstroom uit Investeringsactiviteiten
| -415.544 | -259.115 | -15.786 | 261.072 | -181.634 | -160.375 | -12.265 | -97.797 | -43.684 | -3.576 | -25.909 | -3.779 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -183.293 | -219.74 | -98.849 | -16.606 | -62.648 | -167.178 | 0 | -121.25 | 0 | 0 | -23 | 0 |
| Uitgifte van Gewone Aandelen
| 180.519 | 4.452 | 13.289 | 2.577 | 1.092 | 11.929 | 166.947 | 177.795 | 209.087 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -15.292 | -18.318 | -3.85 | -1.851 | -2.609 | -1.236 | -1.272 | -0.365 | 0 | 0 | -0.1 | 0 |
| Uitgekeerde Dividenden
| -18.793 | -14.884 | -1.3 | -20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -63.679 | 380.031 | 61.162 | 24.018 | 89.751 | 274.024 | -1.39 | -55.651 | 0.152 | -1.365 | 34.386 | 4.5 |
| Kasstroom uit Financieringsactiviteiten
| 281.34 | 131.541 | -29.548 | -11.862 | -35.545 | 274.024 | 165.557 | 122.144 | 209.239 | -1.365 | 34.286 | 4.5 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -0.079 | -0.657 | -0.052 | 0.065 | 0.03 | -0.036 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 8.299 | -139.784 | -6.639 | 233.05 | -259.794 | 92.962 | 125.334 | -11.163 | 145.726 | -80.035 | -5.252 | -12.046 |
| Kaspositie aan het Einde van de Periode
| 223.457 | 215.158 | 354.942 | 361.581 | 128.531 | 388.325 | 295.363 | 134.563 | 145.726 | -80.035 | 0 | 5.252 |